Maic Seegel

Opposite effects of rofecoxib on NF- κ B and AP-1 activation 1

S. Grösch, E. Niederberger, I. Tegeder, 2002 .

Avoiding N-Nitrosodimethylamine Formation in Metformin Pharmaceuticals by Limiting Dimethylamine and Nitrite.

Tim Müller, C. Saal, Joerg Schlingemann, 2022, International journal of pharmaceutics.

Opposite Effects of Rofecoxib on Nuclear Factor-κB and Activating Protein-1 Activation

S. Grösch, G. Geisslinger, E. Niederberger, 2003, Journal of Pharmacology and Experimental Therapeutics.

Peripheral and central antihyperalgesic effects of diclofenac in a model of human inflammatory pain

G. Geisslinger, M. Burian, I. Tegeder, 2003, Clinical pharmacology and therapeutics.

DMSO-enhanced MALDI MS imaging with normalization against a deuterated standard for relative quantification of dasatinib in serial mouse pharmacology studies

C. Hopf, Björn Meyer, Sandra Schulz, 2013, Analytical and Bioanalytical Chemistry.

Cisplatin tumor concentrations after intra‐arterial cisplatin infusion or embolization in patients with oral cancer

B. Turowski, G. Geisslinger, A. Al-Dam, 2003, Clinical pharmacology and therapeutics.

NDMA Analytics in Metformin Products: Comparison of Methods and Pitfalls.

Tony W. T. Bristow, M. Harrison, C. Saal, 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Determination of 8-methoxypsoralen in human plasma, and microdialysates using liquid chromatography-tandem mass spectrometry.

R. Kaufmann, G. Geisslinger, I. Tegeder, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Evidence of COX-2 independent induction of apoptosis and cell cycle block in human colon carcinoma cells after S- or R-ibuprofen treatment.

S. Grösch, G. Geisslinger, T. Maier, 2006, European journal of pharmacology.

Opposite Effects of Rofecoxib on Nuclear Factor- (cid:1) B and Activating Protein-1 Activation

S. Grösch, G. Geisslinger, E. Niederberger, 2003 .